CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

CVS Health Corporation CVS is scheduled to report second-quarter 2025 results on July 31, before the opening bell. In the ...

A federal judge on Wednesday said he will try to issue a ruling soon on whether a new state law banning pharmacies operated ...

Just before President Trump pushed her out at the behest of his corporate donors, former Federal Trade Commission chairwoman Lina Khan released a damning report about the most rapacious and ...

For many years now, the price of insulin has continued to increase, which comes at a cost for those with diabetes who truly depend on the medication to ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

CVS Health has secured a major healthcare deal, winning a multi-year pharmacy benefits contract with CalPERS, outbidding rival UnitedHealth. The deal marks a significant win for CVS's Caremark unit ...

Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

A lawsuit filed in federal court on behalf of the University of Pennsylvania and its health system alleges that 20 years of skyrocketing prices on drugs that treat diabetes, like insulin, can be ...

Novo Nordisk NVO generates most of its revenues from the sales of its blockbuster GLP-1 injections, Ozempic for type II ...

Litigation over state power to regulate pharmacy benefit managers is far from over, even after the US Supreme Court bolstered ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...